You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Colorectal cancer

Aflibercept in combination with irinotecan and fluorouracil-based therapy for treating metastatic colorectal cancer that has progressed following prior oxaliplatin-based chemotherapy

  • Technology appraisal guidance
  • Reference number: TA307
  • Published:  25 March 2014
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Colorectal cancer (metastatic) - aflibercept: Sanofi appeal

  • Colorectal cancer (metastatic) - aflibercept: Sanofi appeal - appeal letter

  • Colorectal cancer (metastatic) - aflibercept: Sanofi appeal - initial scrutiny letter

  • Colorectal cancer (metastatic) - aflibercept: Sanofi appeal - response to initial scrutiny

  • Colorectal cancer (metastatic) - aflibercept: Sanofi appeal - final scrutiny letter


This page was last updated: 22 January 2014

Back to top